Patents by Inventor Kristopher M. Kuchenbecker

Kristopher M. Kuchenbecker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bi-specific therapeutic proteins, in vivo methods of use thereof and encoding nucleic acids thereof
    Patent number: 11879002
    Abstract: Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using such fusion proteins to repair or regenerate damaged or diseased tissue.
    Type: Grant
    Filed: September 28, 2021
    Date of Patent: January 23, 2024
    Assignee: Silver Creek Pharmaceuticals, Inc.
    Inventors: Laura D. J. Antipov, Shawdee Eshghi, Kristopher M. Kuchenbecker, Bjorn L. Millard, Matthew D. Onsum, Andrea D. Nickerson, Timothy R. Stowe, Yan Zhang
  • METHODS OF TREATING SKIN TISSUE DAMAGE
    Publication number: 20220162283
    Abstract: Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using such fusion proteins to repair or regenerate damaged or diseased tissue.
    Type: Application
    Filed: February 10, 2022
    Publication date: May 26, 2022
    Applicant: Silver Creek Pharmaceuticals, Inc.
    Inventors: Laura D.J. Antipov, Shawdee Eshghi, Kristopher M. Kuchenbecker, Bjorn L. Millard, Matthew D. Onsum, Andrea D. Nickerson, Timothy R. Stowe, Yan Zhang
  • Chimeric Proteins and Methods of Use for Treatment of Central Nervous System Disorders
    Publication number: 20220031812
    Abstract: Aspects of the present disclosure relate generally to kits and methods for treating acute central nervous systems disorders with chimeric proteins and pharmaceutical compositions comprising such chimeric proteins.
    Type: Application
    Filed: July 30, 2021
    Publication date: February 3, 2022
    Inventors: Samuel J. Pfaff, Yan Zhang, Kristopher M. Kuchenbecker, Lakhmir Chawla
  • BI-SPECIFIC THERAPEUTIC PROTEINS AND METHOD OF USE THEREOF
    Publication number: 20220009991
    Abstract: Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using such fusion proteins to repair or regenerate damaged or diseased tissue.
    Type: Application
    Filed: September 28, 2021
    Publication date: January 13, 2022
    Inventors: Laura D.J. Antipov, Shawdee Eshghi, Kristopher M. Kuchenbecker, Bjorn L. Millard, Matthew D. Onsum, Andrea D. Nickerson, Timothy R. Stowe, Yan Zhang
  • Method of inhibiting apoptosis or promoting cell survival by providing a bi-specific protein comprising insulin-like growth factor IGF-1 and Annexin A5
    Patent number: 11155593
    Abstract: Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using such fusion proteins to repair or regenerate damaged or diseased tissue.
    Type: Grant
    Filed: March 17, 2020
    Date of Patent: October 26, 2021
    Assignee: Silver Creek Pharmaceuticals, Inc.
    Inventors: Laura D. J. Antipov, Shawdee Eshghi, Kristopher M. Kuchenbecker, Bjorn L. Millard, Matthew D. Onsum, Andrea D. Nickerson, Timothy R. Stowe, Yan Zhang
  • Bi-Specific Therapeutic Proteins for Tissue Repair
    Publication number: 20200207826
    Abstract: Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using such fusion proteins to repair or regenerate damaged or diseased tissue.
    Type: Application
    Filed: March 17, 2020
    Publication date: July 2, 2020
    Inventors: Laura D.J. Antipov, Shawdee Eshghi, Kristopher M. Kuchenbecker, Bjorn L. Millard, Matthew D. Onsum, Andrea D. Nickerson, Timothy R. Stowe, Yan Zhang
  • Method of protecting tissue from damage by administering a bi-specific therapeutic protein comprising insulin-like growth factor 1 (IGF-1) and Annexin A5
    Patent number: 10633425
    Abstract: Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using such fusion proteins to repair or regenerate damaged or diseased tissue.
    Type: Grant
    Filed: July 3, 2018
    Date of Patent: April 28, 2020
    Assignee: Silver Creek Pharmaceuticals, Inc.
    Inventors: Laura D. J. Antipov, Shawdee Eshghi, Kristopher M. Kuchenbecker, Bjorn L. Millard, Matthew D. Onsum, Andrea D. Nickerson, Timothy R. Stowe, Yan Zhang
  • Bi-Specific Therapeutic Proteins for Tissue Repair
    Publication number: 20190169258
    Abstract: Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using such fusion proteins to repair or regenerate damaged or diseased tissue.
    Type: Application
    Filed: July 3, 2018
    Publication date: June 6, 2019
    Inventors: Laura D.J. Antipov, Shawdee Eshghi, Kristopher M. Kuchenbecker, Bjorn L. Millard, Matthew D. Onsum, Andrea D. Nickerson, Timothy R. Stowe, Yan Zhang
  • Bi-specific annexin A5/IGF-1 proteins and methods of use thereof to promote regeneration and survival of tissue
    Patent number: 10040840
    Abstract: Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using such fusion proteins to repair or regenerate damaged or diseased tissue.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: August 7, 2018
    Assignee: Silver Creek Pharmaceuticals, Inc.
    Inventors: Laura D. J. Antipov, Shawdee Eshghi, Kristopher M. Kuchenbecker, Bjorn L. Millard, Matthew D. Onsum, Andrea D. Nickerson, Timothy R. Stowe, Yan Zhang
  • Bi-Specific Therapeutic Proteins for Tissue Repair
    Publication number: 20170096469
    Abstract: Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using such fusion proteins to repair or regenerate damaged or diseased tissue.
    Type: Application
    Filed: September 30, 2016
    Publication date: April 6, 2017
    Inventors: Laura D.J. Antipov, Shawdee Eshghi, Kristopher M. Kuchenbecker, Bjorn L. Millard, Matthew D. Onsum, Andrea D. Nickerson, Timothy R. Stowe, Yan Zhang